News

CRISPRMED24 Testimonial - Pietro De Angeli PhD

CRISPRMED25 is an event not to be missed, but don't take it from us! Hear what some of this year's CRISPRMED attendees have to say about the conference in this new video series by WeDoCRISPR!

By: WeDoCRISPR - Nov. 24, 2024
News

Pietro De Angeli PhD is a Project Lead Scientist in Professor Bernd Wissinger’s team at the Institute for Ophthalmic Research, Tübingen University Hospital, Germany. Here, he is involved in pre-clinical gene-editing research for inherited retinal disorders. Hear what he has to say anout CRISPRMED24!

Tags

HashtagArticleHashtagNewsHashtagWeDoCRISPRHashtagCRISPRMED24HashtagCRISPRMED25

CLINICAL TRIALS
Multiple Sclerosis, (NCT07008378)
Sponsors:
Genentech, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Hemophilia B, (NCT06611436)
Sponsors:
Be Biopharma
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Heterozygous familial hypercholesterolemia, (ChiCTR2400093099)
Sponsors:
Primary sponsor: The First Affiliated Hospital of Bengbu Medical College Primary sponsor's address: 287 Changhuai Road, Longzihu District, Bengbu, Anhui, China Secondary sponsor: Country: China Province: Anhui City: Bengbu Institution hospital: The First Affiliated Hospital of Bengbu Medical College Address: 287 Changhuai Road, Longzihu District
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine